A risk-predictive model for invasive pulmonary aspergillosis in patients with acute exacerbation of chronic obstructive pulmonary disease.

Respiratory Research
Yu GuXin Su

Abstract

Invasive pulmonary aspergillosis (IPA) is increasingly reported in chronic obstructive pulmonary disease (COPD) patients. These patients often have poor clinical outcomes. Early recognition of IPA in COPD is always challenging. We aimed to develop and validate a risk model using readily available clinical parameters to predict IPA for acute exacerbation of COPD (AECOPD) patients. We performed a retrospective cohort study. AECOPD patients who were admitted to Jinling Hospital between January 2012 and December 2017 were included. 880 AECOPD patients were randomly divided into the training set (70%, n = 616) and validation set (30%, n = 264). A nomogram model was developed using multivariate logistic regression from training set. The discrimination and calibration of model were validated internally. Decision curve analyses assessed the clinical utility of the nomogram. The incidence of IPA in hospitalized AECOPD patients was 9.6% in the training set (59 cases of IPA) and 9.1% in the validation set (24 cases of IPA), respectively. The nomogram model consisted of independent factors associated with IPA included lung function GOLD III-IV, use of broad-spectrum antibiotic over 10 days in the last month, oral or intravenous corticoster...Continue Reading

References

Nov 1, 1989·Reviews of Infectious Diseases·A E StuckF J Frey
Sep 9, 2000·The New England Journal of Medicine·B A LeavS Hadley
May 11, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·F AderA Durocher
Oct 2, 2007·The European Respiratory Journal·P BulpaY Sibille
Dec 18, 2008·Source Code for Biology and Medicine·Zoran BursacDavid W Hosmer
Nov 13, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J GuineaE Bouza
Oct 26, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·H XuW-F Yuan
Apr 21, 2012·American Journal of Respiratory and Critical Care Medicine·Stijn I BlotUNKNOWN AspICU Study Investigators
Aug 11, 2012·American Journal of Respiratory and Critical Care Medicine·Jørgen VestboRoberto Rodriguez-Roisin
Aug 1, 2014·Anaesthesiology Intensive Therapy·Suzanne TeeringManu Lng Malbrain
Aug 30, 2014·Critical Care : the Official Journal of the Critical Care Forum·Matteo BassettiMassimo Antonelli
Mar 17, 2015·The Lancet Infectious Diseases·Silke SchelenzUNKNOWN British Society for Medical Mycology
Oct 7, 2015·Statistics in Medicine·Giovanni NattinoGuido Bertolini
Dec 4, 2015·Critical Care : the Official Journal of the Critical Care Forum·Claire DelsucFlorence Ader
Aug 5, 2017·The Lancet Infectious Diseases·Kaitlin BenedictTom Chiller
Sep 29, 2017·The European Respiratory Journal·Pierre BulpaUNKNOWN AspICU study investigators
Mar 17, 2018·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A J UllmannO A Cornely
Sep 23, 2018·European Urology·Ben Van CalsterEwout W Steyerberg
Dec 6, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J Peter DonnellyPeter G Pappas
Mar 9, 2021·Annals of Intensive Care·Joffrey HamamUNKNOWN Collaborative RESSIF group

❮ Previous
Next ❯

Software Mentioned

R
rmda (
rms
GiViTI

Related Concepts

Related Feeds

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

CFTR Mutant Structural Therapy

Over 1700 different mutations in the CFTR genes have been shown to cause cystic fibrosis. Here is the latest research on structural therapy for CFTR mutants.